Pacira BioSciences to Participate in Fireside Chat at the Barclays 28th Annual Global Healthcare Conference

Rhea-AI Summary

Pacira BioSciences (NASDAQ:PCRX) will participate in an analyst-led fireside chat at the Barclays 28th Annual Global Healthcare Conference on March 11, 2026 at 2:30 PM ET in Miami. Live audio will stream on the company Events page and a replay will be available for two weeks.

Key Figures

Conference edition: 28th Event time: 2:30 PM ET Event date: March 11, 2026 +5 more

8 metrics

Conference edition 28th Barclays Annual Global Healthcare Conference

Event time 2:30 PM ET Fireside chat time on March 11, 2026

Event date March 11, 2026 Scheduled conference fireside chat

Replay duration Two weeks Webcast replay availability after the event

Current price $22.10 Pre-news market context for PCRX

52-week range $18.80–$27.64 Low and high prior to this news

Price vs 52-week high -20.04% Distance below 52-week high before the conference news

Short interest 21.51% Short interest as percent of float

Market Reality Check

Price: $22.10 Vol: Volume 1,129,718 is 1.29x...

normal vol

$22.10 Last Close

Volume Volume 1,129,718 is 1.29x the 20-day average of 877,905 shares. normal

Technical Price at $22.10 is trading below the 200-day MA of $23.89 and 20.04% under the 52-week high of $27.64.

Peers on Argus

PCRX was up 3.85% while key peers like COLL and AMPH were down and AVDL was flat...

2 Up

PCRX was up 3.85% while key peers like COLL and AMPH were down and AVDL was flat. Momentum scanner flagged HROW and EVO moving up, but peer moves were mixed and did not match PCRX, indicating stock-specific action around this conference participation.

Common Catalyst Both PCRX and peer HROW issued conference participation announcements in the healthcare space.

Historical Context

5 past events · Latest: Mar 02 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Mar 02	Clinical data update	Positive	-2.9%	Real-world IGOR registry data presented for EXPAREL and iovera° knee treatments.
Feb 26	Earnings results	Positive	-3.0%	Q4 and 2025 results with revenue growth, profitability and 2026 guidance disclosed.
Feb 12	Earnings call date	Neutral	+1.5%	Announcement of timing and access details for 2025 results conference call.
Feb 12	Policy/survey news	Positive	-1.3%	NOPAIN Act survey data highlighting increased non-opioid use and reduced opioid prescribing.
Feb 09	Equity grants	Neutral	+0.3%	Inducement stock options and RSUs granted under Nasdaq Listing Rule 5635(c)(4).

Pattern Detected

Recent positive or neutral news (clinical data, earnings, policy-related updates) has often been followed by flat-to-negative price reactions, showing several divergences between news tone and short-term moves.

Recent Company History

Over the past month, Pacira has reported multiple developments. On Feb 26, it posted Q4 and full-year 2025 results with $726.4M revenue and a return to GAAP profitability, yet shares fell on that day. Earlier in February, it highlighted NOPAIN Act survey data and IGOR registry outcomes for EXPAREL and iovera°, both supportive of its non-opioid strategy. Inducement equity grants and the earnings-date announcement had modest market impact. Today’s Barclays fireside chat fits this pattern of frequent investor-facing communications.

Market Pulse Summary

This announcement outlines Pacira’s participation in a Barclays healthcare conference fireside chat ...

Analysis

This announcement outlines Pacira’s participation in a Barclays healthcare conference fireside chat on March 11, 2026, providing another venue to communicate its non-opioid pain strategy to investors. In recent months, the company released clinical data, policy-related survey findings, and full-year 2025 financials, while the stock traded below its 52-week high with notable short interest of 21.51%. Investors may focus on any incremental commentary relative to those prior disclosures.

AI-generated analysis. Not financial advice.

BRISBANE, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it will participate in an analyst-led fireside chat at the Barclays 28^th Annual Global Healthcare Conference at 2:30 PM ET on Wednesday, March 11, 2026 in Miami. Live audio of the event can be accessed by visiting the “Events” page of the company’s website at investor.pacira.com. A replay of the webcast will also be available for two weeks following the event.

About Pacira
Pacira delivers innovative, non-opioid pain therapies to transform the lives of patients. Pacira has three commercial-stage non-opioid treatments: EXPAREL^® (bupivacaine liposome injectable suspension), a long-acting local analgesic currently approved for infiltration, fascial plane block, and as an interscalene brachial plexus nerve block, an adductor canal nerve block, and a sciatic nerve block in the popliteal fossa for postsurgical pain management; ZILRETTA^® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular injection indicated for the management of osteoarthritis knee pain; and iovera_®º, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. The company is also advancing a pipeline of clinical-stage assets for musculoskeletal pain and adjacencies, its most advanced product candidate, PCRX-201 (enekinragene inzadenovec), a novel locally administered gene therapy in Phase 2 clinical development for osteoarthritis of the knee. To learn more about Pacira, visit www.pacira.com.

Company Contact:
Pacira BioSciences, Inc.
Christian Pedetti
(973) 254-4387
Christian.pedetti@pacira.com

FAQ

When is Pacira BioSciences (PCRX) speaking at the Barclays 2026 conference?

Pacira will speak on March 11, 2026 at 2:30 PM ET. According to the company, the session is an analyst-led fireside chat at the Barclays 28th Annual Global Healthcare Conference in Miami.

How can investors access the Pacira (PCRX) fireside chat webcast on March 11, 2026?

Investors can access live audio via the company Events page at investor.pacira.com. According to the company, the webcast will stream live and a replay will be available for two weeks after the event.

Will there be a replay of the Pacira (PCRX) Barclays fireside chat and for how long?

Yes, a replay will be available for two weeks following the event. According to the company, the replay can be accessed from the same Events page used for the live audio.

What is the format and focus of Pacira's (PCRX) presentation at the March 11, 2026 conference?

The company will appear in an analyst-led fireside chat format at the conference. According to the company, the discussion is expected to cover recent developments and outlook in the healthcare space during the Barclays event.

Where is the Barclays 28th Annual Global Healthcare Conference being held for Pacira's (PCRX) session?

The conference is taking place in Miami, with Pacira's session scheduled on March 11, 2026 at 2:30 PM ET. According to the company, the event includes in-person presentations and live audio streaming options.